There is currently no official link or approved indication for using GLP-1 receptor agonists specifically to treat Hashimoto's thyroiditis or its symptoms
However, these findings are relatively rare
The weight loss pattern continued, and participants lost an average of 14.9% of their body weight after 68 weeks
Regular monitoring is important for all patients on GLP-1 therapy
How to manage it: Stay hydrated by drinking plenty of water, as dehydration can make symptoms worse
While effective, they come with notable side effects, including nausea, digestive issues and some serious issues : Vision Impairment Alert Semaglutide, a widely used GLP-1 receptor agonist, has been linked to a significantly higher rate of reported vision problems